{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:49:23Z","timestamp":1791532163481,"version":"4.3.4"},"reference-count":12,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtct.2026.05.038","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:20:02Z","timestamp":1779985202000},"page":"1305.e1-1305.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Addition of High-Dose Cytarabine to Fludarabine, Busulfan, and Melphalan Conditioning for Cord Blood Transplantation in Adult Acute Myeloid Leukemia"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8238-8672","authenticated-orcid":false,"given":"Kyosuke","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otoya","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Mitsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosei","family":"Kageyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Taya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Ishiwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1687-7029","authenticated-orcid":false,"given":"Hisashi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Asano-Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Wake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5952-5926","authenticated-orcid":false,"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.05.038_bib0001","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood-2015-04-642652","article-title":"Efficiency of high-dose cytarabine added to CY\/TBI in cord blood transplantation for myeloid malignancy","volume":"126","author":"Arai","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.05.038_bib0002","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/bmt.2016.242","article-title":"High-dose cytarabine added to CY\/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort study","volume":"51","author":"Arai","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.05.038_bib0003","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.bbmt.2016.06.017","article-title":"A novel reduced-toxicity myeloablative conditioning regimen using full-dose busulfan, fludarabine, and melphalan for single cord blood transplantation provides durable engraftment and remission in nonremission myeloid malignancies","volume":"22","author":"Yamamoto","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.05.038_bib0004","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"Dohner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.05.038_bib0005","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.05.038_bib0006","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.05.038_bib0007","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41409-025-02508-2","article-title":"Myeloablative conditioning in cord blood transplantation for acute myeloid leukemia patients is efficacious only until age 55","volume":"60","author":"Oshima","year":"2025","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.05.038_bib0008","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2010-07-295279","article-title":"A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study","volume":"117","author":"Miyawaki","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.05.038_bib0009","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1080\/10428194.2020.1805112","article-title":"High-dose cytarabine chemotherapy (>\/=4 g\/m(2)\/day) before allogeneic hematopoietic stem cell transplantation for non-core-binding-factor AML in the first complete remission","volume":"61","author":"Nagahata","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2026.05.038_bib0010","doi-asserted-by":"crossref","first-page":"775.e771","DOI":"10.1016\/j.jtct.2022.07.026","article-title":"Favorable outcome with conditioning regimen of Flu\/Bu4\/Mel in acute myeloid leukemia patients in remission undergoing cord blood transplantation","volume":"28","author":"Mizuno","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.05.038_bib0011","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12185-018-2562-8","article-title":"Addition of melphalan to fludarabine\/busulfan (FLU\/BU4\/MEL) provides survival benefit for patients with myeloid malignancy following allogeneic bone-marrow transplantation\/peripheral blood stem-cell transplantation","volume":"109","author":"Ueda","year":"2019","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2026.05.038_bib0012","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/jha2.947","article-title":"Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: a multicenter retrospective study","volume":"5","author":"Jiang","year":"2024","journal-title":"EJHaem"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726004264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726004264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:57:33Z","timestamp":1791529053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726004264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2666636726004264"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.05.038","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Addition of High-Dose Cytarabine to Fludarabine, Busulfan, and Melphalan Conditioning for Cord Blood Transplantation in Adult Acute Myeloid Leukemia","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.05.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}